LIU Yang, ZHENG Min, YIN Wen-hao, BAO Zhang. Detection of Serum HGF and MMP-9 and Its Clinical Significance in Pat ients with Systemic Lupus Erythematosus[J].Chinese Journal of Dermatology, 2004, 37(12): 703-705.
[1] No authors listed. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.Arthritis Rheum, 1999, 42:1785-1796. [2] 郑敏,朱铁城.SLE患者B淋巴细胞增殖功能测定及其临床意义.中华皮肤科杂志,1990,23:90-92. [3] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35:630-640. [4] Robak E, Wozniacka A, Sysa-Jedrzejowska A, et al. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity. Eur Cytokine Netw, 2001, 12:445-452. [5] Yo Y, Morishita R, Yamamoto K, et al. Actions of hepatocyte growth factor as a local modulator in the kidney:potential role in pathogenesis of renal disease. Kidney Int, 1998, 53:50-58. [6] Sato Y, Fujimoto S, Hamai K, et al. Serial alterations of glomerular matrix-degrading metalloproteinase activity in anti-thymocyte-induced glomerulonephritis in rats. Nephron, 1998, 78:195-200. [7] Skrtic S, Ohlsson C. Cortisol decreases hepatocyte growth factor levels in human osteoblast-like cells. Calcif Tissue Int, 2000, 66:108-112. [8] Sharif M, Salisbury C, Taylor DJ, et al. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. Arthritis Rheum, 1998,41:1203-1209.